ID   SCAF8_RAT               Reviewed;        1268 AA.
AC   Q63623;
DT   18-MAY-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 138.
DE   RecName: Full=SR-related and CTD-associated factor 8 {ECO:0000303|PubMed:9528809};
DE   AltName: Full=RNA-binding motif protein 16 {ECO:0000305};
GN   Name=Scaf8 {ECO:0000303|PubMed:9528809, ECO:0000312|RGD:708362};
GN   Synonyms=Rbm16 {ECO:0000312|RGD:708362};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH POLR2A.
RC   TISSUE=Hippocampus;
RX   PubMed=8692929; DOI=10.1073/pnas.93.14.6975;
RA   Yuryev A., Patturajan M., Litingtung Y., Joshi R.V., Gentile C., Gebara M.,
RA   Corden J.L.;
RT   "The C-terminal domain of the largest subunit of RNA polymerase II
RT   interacts with a novel set of serine/arginine-rich proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:6975-6980(1996).
RN   [2]
RP   INTERACTION WITH POLR2A, AND SUBCELLULAR LOCATION.
RX   PubMed=9528809; DOI=10.1128/mcb.18.4.2406;
RA   Patturajan M., Wei X., Berezney R., Corden J.L.;
RT   "A nuclear matrix protein interacts with the phosphorylated C-terminal
RT   domain of RNA polymerase II.";
RL   Mol. Cell. Biol. 18:2406-2415(1998).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-617, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Anti-terminator protein required to prevent early mRNA
CC       termination during transcription. Together with SCAF4, acts by
CC       suppressing the use of early, alternative poly(A) sites, thereby
CC       preventing the accumulation of non-functional truncated proteins.
CC       Mechanistically, associates with the phosphorylated C-terminal
CC       heptapeptide repeat domain (CTD) of the largest RNA polymerase II
CC       subunit (POLR2A), and subsequently binds nascent RNA upstream of early
CC       polyadenylation sites to prevent premature mRNA transcript cleavage and
CC       polyadenylation. Independently of SCAF4, also acts as a positive
CC       regulator of transcript elongation. {ECO:0000250|UniProtKB:Q9UPN6}.
CC   -!- SUBUNIT: Interacts with POLR2A; via C-terminal heptapeptide repeat
CC       domain (CTD) phosphorylated at 'Ser-2' and 'Ser-5' (PubMed:8692929,
CC       PubMed:9528809). Identified in a complex with CDC5L and other
CC       spliceosomal proteins (By similarity). {ECO:0000250|UniProtKB:Q9UPN6,
CC       ECO:0000269|PubMed:8692929, ECO:0000269|PubMed:9528809}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9528809}. Nucleus
CC       matrix {ECO:0000269|PubMed:9528809}. Note=Detected in granular nuclear
CC       foci which correspond to sites of active transcription.
CC       {ECO:0000250|UniProtKB:Q9UPN6}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U49055; AAC52656.1; -; mRNA.
DR   PIR; T31420; T31420.
DR   RefSeq; NP_620794.1; NM_139094.1.
DR   AlphaFoldDB; Q63623; -.
DR   SMR; Q63623; -.
DR   STRING; 10116.ENSRNOP00000062541; -.
DR   iPTMnet; Q63623; -.
DR   PhosphoSitePlus; Q63623; -.
DR   jPOST; Q63623; -.
DR   PaxDb; 10116-ENSRNOP00000062541; -.
DR   GeneID; 245926; -.
DR   KEGG; rno:245926; -.
DR   UCSC; RGD:708362; rat.
DR   AGR; RGD:708362; -.
DR   CTD; 22828; -.
DR   RGD; 708362; Scaf8.
DR   eggNOG; KOG0132; Eukaryota.
DR   InParanoid; Q63623; -.
DR   OrthoDB; 5406494at2759; -.
DR   PhylomeDB; Q63623; -.
DR   PRO; PR:Q63623; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005849; C:mRNA cleavage factor complex; IBA:GO_Central.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0019904; F:protein domain specific binding; IMP:RGD.
DR   GO; GO:0003723; F:RNA binding; ISS:UniProtKB.
DR   GO; GO:0070063; F:RNA polymerase binding; IPI:UniProtKB.
DR   GO; GO:0043175; F:RNA polymerase core enzyme binding; ISO:RGD.
DR   GO; GO:1990269; F:RNA polymerase II C-terminal domain phosphoserine binding; ISS:UniProtKB.
DR   GO; GO:0000993; F:RNA polymerase II complex binding; IBA:GO_Central.
DR   GO; GO:0006397; P:mRNA processing; IMP:RGD.
DR   GO; GO:2000805; P:negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled; ISS:UniProtKB.
DR   GO; GO:0032786; P:positive regulation of DNA-templated transcription, elongation; ISS:UniProtKB.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; IBA:GO_Central.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IMP:RGD.
DR   CDD; cd17004; CID_SCAF8; 1.
DR   CDD; cd12462; RRM_SCAF8; 1.
DR   Gene3D; 1.25.40.90; -; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR006569; CID_dom.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034370; SCAF8_RRM.
DR   InterPro; IPR051485; SR-CTD_assoc_factor.
DR   PANTHER; PTHR23140:SF1; PROTEIN SCAF8 ISOFORM X1; 1.
DR   PANTHER; PTHR23140; RNA PROCESSING PROTEIN LD23810P; 1.
DR   Pfam; PF04818; CID; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00582; RPR; 1.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF48464; ENTH/VHS domain; 1.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS51391; CID; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   Isopeptide bond; Methylation; Nucleus; Phosphoprotein; Reference proteome;
KW   RNA-binding; Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..1268
FT                   /note="SR-related and CTD-associated factor 8"
FT                   /id="PRO_0000394195"
FT   DOMAIN          1..139
FT                   /note="CID"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00724"
FT   DOMAIN          477..551
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          322..355
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          385..469
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          753..808
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          947..1063
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1199..1268
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        398..441
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        442..465
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        947..974
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1037..1063
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1235..1251
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         6
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UPN6"
FT   MOD_RES         273
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UPN6"
FT   MOD_RES         615
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UPN6"
FT   MOD_RES         617
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         915
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UPN6"
FT   MOD_RES         925
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UPN6"
FT   MOD_RES         936
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UPN6"
FT   MOD_RES         1071
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6DID3"
FT   CROSSLNK        18
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UPN6"
SQ   SEQUENCE   1268 AA;  139504 MW;  516022F8E284126E CRC64;
     MEAVKTFNSE LYSLNDYKPP ISKAKMTQIT KAAIKAIKFY KHVVQSVEKF IQKCKPEYKV
     PGLYVIDSIV RQSRHQVGQE KDVCAPRFSN NIISTFQNLY RCPGDDKSKI VRVLNLWQKN
     NVFKSEIIQP LLDMAAGIPP PVVTPVLAST TVAMSNTPGT PVTPVTPANV VQGLPDPWVS
     QITNTDTLAA VAQILQSPQG QQLQQLIQTL QIQQQKPQPS ILQALDAGLV VQLQALTAQL
     TAAAAAANTL TPLDQGVSFN KKLMDRFDFG EDSEHSEESK KEIPTPQLSH VSESVNNSIF
     HQIAEQLQQQ NLEQLRQQLL EQQQPQKVTP QDSQEGAFGS EHSASPSQGS SQQHFLEPEA
     NLDDSIDIQQ QDMDIDEGQD VVEEEIFEPE AKKVAVRSRS RTHSRSRSRS PRKRRSRSRS
     GSRKRKHRKR SRSRSRERKR KSSRSYSSER RAREREKERQ KKGLPPVRSK TLSVCSTTLW
     VGQVDKKATQ QDLTNLFEEF GQIESINMIP PRGCAYVCMV HRQDSFRALQ KLSSGSYKIG
     SKVIKIAWAL NKGVKTEYKQ FWDVDLGVTY IPWEKVKVDD LDGFAEGGMI DQETVNAEWE
     TVKTSEPVKE TVQTTQSPAA VEKETVVTTQ SEVFPPPVTM LQIPVAPTVP AVSLVPPAFP
     VSMPVPPPGF SPIPPPPFLR ASFNPSQPPP GFMPPPVPPP VVPPPAIPPV VPTSLVQPPL
     SMTPETVKDV GFGSLVLPGG SVAGNLAPST LPAGNVFNPP SKAEPEEKVP HLTEHQIPSG
     ENTRPVIPSD IPSSAPMLAQ PPGASNTSGI LCVQRPNVSS NSEILGVRPA NVSNSAAIMG
     AQPPNMLNNS GILGIQPPNV SSGSGLLGVL PPNLPNNSGL VGLQPPNVTN PAGLLGTQPP
     IGPQNLPPLT IPAQRMPALP MLDIRPGLIA QAPGPRFPLL QPGIPPQRGI PPPSVLDAAL
     HPPPRGPFPP GDLFSQPERP FLAPGRPNID SVPNPDKRIP LGNDNIQQEG DRDYRFPPIE
     TREGINRPPP VDVRDVVGRP IDPREGPGRP PLDGRDHFGR PPVDMRETLV RPGLDHLGRR
     DHFGFPPEKP WGPRDFDERE HRVLPVFGGP KGLHEERGRF RAGNYRFDPR SGPWNRGFGQ
     EVHRDFDDRR RPWERQRDRD DRDFDFCREI NGNRLGRDRI QNTWVPPPHA RVFDYFEGAT
     SQRKGENVPQ VNGGNTERHA PPPPLPVQKD PELYEKLASS GDADKEESGT AAGVESEAVV
     ESTETEGT
//
